Aspire Biopharma Holdings, Inc. Common Stock (ASBP) Q1 2025 Annual Earnings
ASBP·Reported May 14, 2025·Before market open
Diluted EPS came in at $-0.42 (-512.2% YoY).
Diluted EPS
$-0.42
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Aspire Biopharma Holdings, Inc. Common Stock's Q1 2025 earnings report.
Aspire Biopharma Holdings, Inc. Common Stock (ASBP) reported Q1 2025 earnings on May 14, 2025 before market open.
Aspire Biopharma Holdings, Inc. Common Stock reported diluted EPS of $-0.42 for Q1 2025.
Compared to the same quarter a year prior, diluted EPS declined 512.2% from $-0.07.
You can read the 10-K periodic report (0001641172-25-002917) directly on SEC EDGAR. The filing index links above go to sec.gov.